Daptomycin versus teicoplanin in the treatment of osteomyelitis: Results of the Göztepe retrospective cohort study.

Sipahi, O; Erdem, H; Kahraman, HASİP; Kurşun, E; Suntur, B; Demirdal, T; Nemli, S; Dizbay, M; Ulug, M; Öztoprak-Cuvalci, N; Arda, B; Quliyeva, G; Tasbakan, M; Uysal, S; Sipahi, H; Aydemir, S; Ulusoy, S

doi:10.1016/j.idnow.2021.01.009

Daptomycin versus teicoplanin in the treatment of osteomyelitis: Results of the Göztepe retrospective cohort study.

Copy For Citation

Sipahi O. R., Erdem H. A., Kahraman H., Kurşun E., Suntur B. M., Demirdal T., ...More

Infectious diseases now, vol.51, no.4, pp.362-367, 2021 (SCI-Expanded)

Publication Type: Article / Article
Volume: 51 Issue: 4
Publication Date: 2021
Doi Number: 10.1016/j.idnow.2021.01.009
Journal Name: Infectious diseases now
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.362-367
Eskisehir Osmangazi University Affiliated: Yes

Abstract

Objectives: Daptomycin is highly effective against Gram-positive multidrug-resistant bacteria. Publications on daptomycin in osteomyelitis treatment are limited.